Objective: To develop a new curriculum for a master's degree in nursing and provide a reference for nursing education in China. Methods: After a comprehensive literature review and item consolidation, an expert pan...Objective: To develop a new curriculum for a master's degree in nursing and provide a reference for nursing education in China. Methods: After a comprehensive literature review and item consolidation, an expert panel developed the initial version of the master's degree program objective and curriculum. A three-round Delphi study was subsequently conducted to revise and validate the curriculum. Results: Twenty-six experts participated in the evaluation and validation process. The authority coef- ficient was 0.88, and the Kendall coordination coefficient was statistically significant (X2 test, P 〈 0.01). The final training objective contained 9 items, covering knowledge, skills and humanistic quality. The final established curriculum contained 22 courses, including 5 public compulsory courses, 5 specialized basic compulsory courses and 12 elective courses for professional development. Conclusions: The present study provided an operational curriculum for a master's degree in nursing in China.展开更多
Interleukin-37b(hereafter called IL-37)was identified as fundamental inhibitor of natural and acquired immunity.The molecular mechanism and function of IL-37 in colorectal cancer(CRC)has been elusive.Here,we found tha...Interleukin-37b(hereafter called IL-37)was identified as fundamental inhibitor of natural and acquired immunity.The molecular mechanism and function of IL-37 in colorectal cancer(CRC)has been elusive.Here,we found that IL-37 transgenic(IL-37tg)mice were highly susceptible to colitis-associated colorectal cancer(CAC)and suffered from dramatically increased tumor burdens in colon.Nevertheless,IL-37 is dispensable for intestinal mutagenesis,and CRC cell proliferation,apoptosis,and migration.Notably,IL-37 dampened protective cytotoxic T cell-mediated immunity in CAC and B16-OVA models.CD8^(+)T cell dysfunction is defined by reduced retention and activation as well as failure to proliferate and produce cytotoxic cytokines in IL-37tg mice,enabling tumor evasion of immune surveillance.The dysfunction led by IL-37 antagonizes IL-18–induced proliferation and effector function of CD8+T cells,which was dependent on SIGIRR(single immunoglobulin interleukin-1 receptor-related protein).Finally,we observed that IL-37 levels were significantly increased in CRC patients,and positively correlated with serum CRC biomarker CEA levels,but negatively correlated with the CD8+T cell infiltration in CRC patients.Our findings highlight the role of IL-37 in harnessing antitumor immunity by inactivation of cytotoxic T cells and establish a new defined inhibitory factor IL-37/SIGIRR in cancerimmunity cycle as therapeutic targets in CRC.展开更多
基金supported by the Key Project of Graduate Education Reform of Chongqing Commission of Education(No.yjg110226)National Development Funds for Key Clinical Specialties(No.2013-544)
文摘Objective: To develop a new curriculum for a master's degree in nursing and provide a reference for nursing education in China. Methods: After a comprehensive literature review and item consolidation, an expert panel developed the initial version of the master's degree program objective and curriculum. A three-round Delphi study was subsequently conducted to revise and validate the curriculum. Results: Twenty-six experts participated in the evaluation and validation process. The authority coef- ficient was 0.88, and the Kendall coordination coefficient was statistically significant (X2 test, P 〈 0.01). The final training objective contained 9 items, covering knowledge, skills and humanistic quality. The final established curriculum contained 22 courses, including 5 public compulsory courses, 5 specialized basic compulsory courses and 12 elective courses for professional development. Conclusions: The present study provided an operational curriculum for a master's degree in nursing in China.
基金This work was supported by the National Natural Science Foundation of China(81472650,81602763,81573050,82003358,81673061,81703132,31872739,31271483)the Key Research and Development Program of Sichuan Province[2020YFS0271]+5 种基金Project funded by China Postdoctoral Science Foundation(2016M592673,2018M631087,and 2017T100700)the Sichuan Provincial Outstanding Youth Fund(2015JQ0025)the Postdoctoral Fund for West China Hospital(2019HXBH075)the Fundamental Research Funds for the Central Universities(2019SCU12041,the Postdoctoral Foundation of Sichuan University)the National Science and Technology Major Project(2018ZX09733001-001-006 and 2019ZX09201003-003)the Sichuan Science and Technology Program(2021YJ0420).
文摘Interleukin-37b(hereafter called IL-37)was identified as fundamental inhibitor of natural and acquired immunity.The molecular mechanism and function of IL-37 in colorectal cancer(CRC)has been elusive.Here,we found that IL-37 transgenic(IL-37tg)mice were highly susceptible to colitis-associated colorectal cancer(CAC)and suffered from dramatically increased tumor burdens in colon.Nevertheless,IL-37 is dispensable for intestinal mutagenesis,and CRC cell proliferation,apoptosis,and migration.Notably,IL-37 dampened protective cytotoxic T cell-mediated immunity in CAC and B16-OVA models.CD8^(+)T cell dysfunction is defined by reduced retention and activation as well as failure to proliferate and produce cytotoxic cytokines in IL-37tg mice,enabling tumor evasion of immune surveillance.The dysfunction led by IL-37 antagonizes IL-18–induced proliferation and effector function of CD8+T cells,which was dependent on SIGIRR(single immunoglobulin interleukin-1 receptor-related protein).Finally,we observed that IL-37 levels were significantly increased in CRC patients,and positively correlated with serum CRC biomarker CEA levels,but negatively correlated with the CD8+T cell infiltration in CRC patients.Our findings highlight the role of IL-37 in harnessing antitumor immunity by inactivation of cytotoxic T cells and establish a new defined inhibitory factor IL-37/SIGIRR in cancerimmunity cycle as therapeutic targets in CRC.